The Effect of Fatima Ana's Hand on Birth Pain and Duration

November 13, 2023 updated by: KTO Karatay University

The Effect of Fatima Ana's Hand (Anastatica Hierochuntica) on Birth Pain and Duration: A Randomized Controlled Study

Research Question: Does the Anastatica Hierochuntica have an effect on labor pain and duration? Methods: This study was planned as a a double blind randomized controlled experimental study. The study was conducted with 60 pregnant women who were randomized between February 2019 and November 2020 at a university and private hospital located in Anatolia, Turkey.

Study Overview

Status

Completed

Conditions

Detailed Description

Complementary treatment methods during the birth process are supportive therapies. It is applied to meet the physical and psychological care needs, to help cope with pain during childbirth, to increase the quality of life of pregnant women. Mind-body methods, alternative medical methods, biological-based treatment methods, manipulative and body-based methods, and energy therapy methods are used as complementary treatment methods in labor. The focus applied within the scope of mind-body methods is based on the principle of revealing the mental skill that improve bodily functions. One of the methods applied in this direction is Anastatica Hierochuntica.

Anastatika Hierochuntica is a herbaceous plant that can live 1000-2000 years, with dry leaves resembling a fist-closed hand in which it stores its seeds. Known as "Fatma Ana Eli" or "Meryem Ana Eli". This dry ball-shaped plant in the deserts of Namibia comes alive in the rain and turns to green color by opening the folds. After the rain, the leaves of the plant, which stores some water to pass through a new drought period, close again and take a dry appearance.

The plant Anastatica Hierochuntica is known to have a facilitating effect on labor and is frequently used for this purpose during labor. During childbirth, the Anastatica Hierochuntica plant is dropped into a bowl of water. It is believed that as the plant opens, labor will be easier, and the baby will flow like water.

Despite its frequent use, when the literature is examined, no studies hasve been found on the effect of Anastatica Hierochuntica on birth. For this reason, the study was conducted to evaluate the effect of Anastatica Hierochuntica on labor pain and duration.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karatay
      • Konya, Karatay, Turkey
        • KTO Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Having a singleton pregnancy at 38-42 weeks,
  • Pregnant women who had spontaneous labor,
  • Pregnant women with a healthy fetus,
  • Pregnant women without any complications that may cause dystocia during labor,
  • Pregnant women who did not receive analgesia and anesthesia during the first phase of labor,
  • Planned vaginal delivery, pregnant women who volunteered to participate in the research

Exclusion Criteria:

pregnant women with high-risk pregnancies, Planned caesarean delivery, pregnant women with chronic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Anastatica Hierochuntica
During the sampling process, the researcher inquired through women who apply for pregnancy follow-up and contacted the mothers who had some inclusion criteria. Also, the researcher outlined the research plan and objectives. The participants were assessed based on the eligibility criteria and, if they were eligible and willing to participate in the study.
No Intervention: Control group
routine care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of labor pain
Time Frame: 12 hours
The primary outcomes included the severity of labor pain that was measured by VAS
12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of the active phase of labor
Time Frame: 12 hours
The secondary outcomes included the duration of the active phase of labor and the second stage of delivery. The length of delivery stages was recorded in the partograph chart during labor and childbirth by the researcher.
12 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hediye KARAKOC, PhD, Karatay University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

November 1, 2021

Study Completion (Actual)

November 1, 2021

Study Registration Dates

First Submitted

November 27, 2021

First Submitted That Met QC Criteria

January 18, 2022

First Posted (Actual)

January 19, 2022

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 13, 2023

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KaratayUNI

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Anastatica Hierochuntica

Subscribe